EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 11800 participants.

Also called NCT07064473

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 11,800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07064473
  • WHO UTN U1111-1319-9064
  • EU CT 2025-521188-11-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong SAR China, Hungary, India, Ireland, Israel, Italy, Japan, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Puerto Rico, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Türkiye, United Kingdom, Vietnam (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07064473. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-22 (actual); primary completion 2029-12-14 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Condition
Diabetes Mellitus, Type 2
Condition
Hypertension
Condition
Cardiovascular Diseases
Intervention (Drug)
Vicadrostat
Intervention (Drug)
Empagliflozin
Intervention (Drug)
Placebo matching Vicadrostat
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct07064473
Content hash
e6512b246efe37a59d8d22c46706b760d7b108c320caff2957d84c5555040912